In a placebo controlled crossover study of 45 men with low normal testosterone, raising levels from about 310 to 510 ng/dL did nothing for energy, libido or mood that the placebo did not also do, and roughly 70 percent of men who start testosterone quit within a year.
- What to do: Before any prescription, get symptoms plus a confirmed low morning level and a broad workup covering SHBG, free testosterone, thyroid, iron and a sleep apnea screen, and treat reversible causes like visceral fat and poor sleep first.
- Why it matters: A quarter of men starting therapy never had a level drawn and about 1 in 5 tested did not meet criteria, yet only 1 in 10 genuinely deficient men get treated, so the system is misaimed rather than simply over or under prescribing.
- How to apply it: If treatment is warranted, aim for the mid range of 450 to 600 ng/dL measured between doses, use one or two injections per week, and run it as a 3 to 9 month trial you can stop.
- Metrics: TRAVERSE followed more than 5,000 men for two years and found about 7 percent cardiac events in both groups, testosterone and placebo had near identical prostate cancer rates, and a hematocrit above 54 percent is the flag for erythrocytosis.
- Risks: Exogenous testosterone suppresses sperm production and is a leading medically induced cause of male infertility, with recovery of 6 to 12 months or never, so discuss fertility, hCG or clomiphene before the first dose.